Skip to content

Clinical trials

Anemia, Sickle Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Country / region: Netherlands Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20132
20141
20151
20161
20171
20182
20192
20201
20214
20227
20232
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status6
Active, not recruiting4
Recruiting3
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)9
Novartis Pharmaceuticals3
Pfizer3
Agios Pharmaceuticals, Inc.2
Hoffmann-La Roche2
Hospital Universitari Vall d'Hebron Research Institute2
CSL Behring1
Cardurion Pharmaceuticals, Inc.1
Dr. Marjon H. Cnossen MD PhD1
Modus Therapeutics AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell29
Vaso-Occlusive Crises3
Hematologic Diseases2
Pain2
Albuminuria1
Anemia1
Anemia, Diamond-Blackfan1
Chronic Disease1
Hemoglobin SC Disease1
Primary Myelofibrosis1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.